Cadrenal Therapeutics, Inc. 8-K

What Happened

• Cadrenal Therapeutics (CVKD) filed an 8-K reporting that Matthew K. Szot and the company mutually agreed to his transition from the role of Chief Financial Officer, effective May 28, 2026.
• The company appointed Chief Executive Officer Quang X. Pham (age 61) as interim Chief Financial Officer and interim Principal Accounting Officer pending a permanent hire. Mr. Pham has served as the company’s CEO since he formed it and previously held leadership roles at Espero BioPharma and several life sciences and marketing firms.
• On June 3, 2026 the company and Mr. Szot executed a Severance and Release Agreement that sets out cash severance, bonus payment terms, and accelerated vesting of his outstanding stock options.

Key Details

• Effective date of CFO transition: May 28, 2026; interim CFO/principal accounting officer: Quang X. Pham.
• Severance payment: $365,806 gross, to be paid in four equal installments of $91,451.50 (payments scheduled the day after the seven‑day revocation period, July 3, Aug 3, and Sept 3, 2026).
• FY2026 annual target cash bonus: $237,903 gross, to be paid in two equal installments of $118,951.50 (the day after the revocation period and July 3, 2026).
• Equity treatment: accelerated vesting of all outstanding stock options issued to Mr. Szot; those options remain exercisable until their original expiration date. The severance agreement includes a seven‑day revocation period, a general release of claims, and a non‑disparagement clause.

Why It Matters

• For investors, the company has temporarily consolidated CEO and CFO duties in one person, which affects financial leadership and reporting continuity until a permanent CFO is hired.
• The company has a near‑term cash obligation of roughly $603,709 (severance plus target bonus) subject to the revocation period and standard withholdings, and accelerated option vesting may affect option exercise timing.
• The filing signals management transition risk and additional cash and equity considerations; the company is actively searching for a permanent CFO.